COMPOUND WITH CONFIDENCE: PCCA Membership, $895/month.

Notice

Our blog search feature is temporarily unavailable while we work to resolve an issue. We apologize for the inconvenience and appreciate your patience. We’ll restore it as soon as possible.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

202205_-Blog_LeverageScience_1768x923.jpg

As the compounding industry continues to grow, expectations for pharmacy compounders grow as well. Vigorous research and transparent scientific data are paramount to proving and promoting the impact of compounded medicines on patients.

Glycopyrrolate_Lollipops_for_Adults_and_Topical_Fluoxetine_for_Cats_New_Case_Studies.jpg

Two recent compounding case studies describe treatments that helped adults with persistent drooling as well as cats with behavioral issues.

Recent_Product_Development_Clinical_Research_and_Formulation_Studies_from_PCCA.jpg

PCCA's Chief Scientific Officer Gus Bassani provides an important and exciting update regarding the work of our Research and Development department over the last 18 months.